Ahead of tomorrow's AGM - interesting to analyse the valuations of investments.
1.. Why do so many of the entire annual gains for AATG fall in the 10 days after the merger with KAY? Were the shareholders defrauded? Who knew what and when?
It seems inherently implausible that the net £1m uplift in the Academia holding (entirely KAY) should not have been reflected in the merger terms.
There are other examples. Looks a bit like pre-booking income for fee purposes and PR.
2. OVIVA: (3rd largest asset) Now here is an interesting case - the entirety of the gains since original investment are solely revaluations arising from £stg collapse against Swiss Franc.
What is OVIVA's present state with the NHS? Reports seem to vary. Worldwide Turnover is still reported as <25m.
3. PHASECRAFT seems that there is a 50% anticipatory uplift ahead of the recent Series B issue in May. Who knew what and when? Will the balance be claimed tomorrow in the 1/4ly update?
4. GRAVITEE TOPCO (2nd largest asset). same situation as PHASECRAFT.
5. QUANTEXA - much more to come in the next few days.
Let us see what tomorrow's preAGM RNS brings.
Comments
Post a Comment